Action GTAB B GLYCOREX TRANSPLANTATION AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Glycorex Transplantation AB

Actions

GTAB B

SE0000524530

Cours en clôture NORDIC GROWTH MARKET
Autres places de cotation
 00:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
1,05 SEK -0,47% Graphique intraday de Glycorex Transplantation AB +1,45% -20,75%
23/05 Glycorex Transplantation AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
28/02 Glycorex Transplantation AB (publ) annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation
First publication from South Africa and first stem cell transplantation performed in Mexico
Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
Glycorex Transplantation AB (publ): Interim Report January - September 2023
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Glycorex Transplantation AB (publ): Interim Report January - June 2023
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Glycorex Transplantation AB (publ): Interim Report January - March 2023
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Annual Report 2022 Glycorex Transplantation AB (publ)
Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa
Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth
Glycorex Transplantation AB (GTAB B): Interim report January - September 2022
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action GTAB B
  4. Actualités Glycorex Transplantation AB
  5. Autres langues